Biohaven (BHVN) Net Equity Issued and Repurchased (2023 - 2026)
Biohaven (BHVN) reported Net Equity Issued and Repurchased of $178.88 million for Q1 2026, compared with $369,000 a year earlier and down 4.6% from the prior quarter.
Powered by 
Analysis
Biohaven (BHVN) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
For FY2025, Biohaven posted Net Equity Issued and Repurchased of $189.18 million, down 71.6% from FY2024.
- Net Equity Issued and Repurchased has a four-year compound annual growth rate of 367.8% (FY2021 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $666.17 million in FY2024 (+173.9%), $243.23 million in FY2023 (-14.3%), $283.8 million in FY2022 and $395,000 in FY2021.
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$1.13 million in Q3 2023 and a high of $316.32 million in Q2 2024.
- Year over year, Net Equity Issued and Repurchased gained in 1 of the last five quarters, with an average decline of 60.4%.
- Per Business Quant data, the three quarters before Q1 2026 came in at $187.61 million (Q4 2025), $122,000 (Q3 2025) and $1.08 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Biohaven | 1.94 Bn | 748.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 178.88 Mn |
| Dec 31, 2025 | 187.61 Mn |
| Sep 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 271.28 Mn |
| Sep 30, 2024 | 76.36 Mn |
| Jun 30, 2024 | 316.32 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 243.23 Mn |
| Sep 30, 2023 | -1.13 Mn |
| Jun 30, 2023 | 794,000.00 |
| Mar 31, 2023 | 332,000.00 |
API Access
Biohaven Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BHVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BHVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BHVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();